Description
NLG919 is an inhibitor of indoleamine-2,3-dioxygenase (IDO). This compound displays anticancer chemotherapeutic activity, prolonging survival rates in animal models of glioblastoma.
Product Unit Size | Cost | Quantity | Stock |
---|
NLG919 is an inhibitor of indoleamine-2,3-dioxygenase (IDO). This compound displays anticancer chemotherapeutic activity, prolonging survival rates in animal models of glioblastoma.
Cas No. | 1402836-58-1 |
---|---|
Purity | ≥98% |
Formula | C18H22N2O |
Formula Wt. | 282.39 |
Chemical Name | 1-Cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol |
IUPAC Name | 1-Cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol |
Synonym | NLG919 (GDC-0919), GTPL9019 |
Solubility | Ethanol 30 mg/mL (106.23 mM) DMSO 15 mg/mL warmed (53.11 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Vacchelli E, Aranda F, Eggermont A, et al. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 2014 Dec 15;3(10):e957994. PMID: 25941578.
Li M, Bolduc AR, Hoda MN, et al. The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma. J Immunother Cancer. 2014 Jul 7;2:21. PMID: 25054064.
Peptide fragment of HER2/neu/erbB2 receptor.
Tetracycline; protein translation inhibitor, MM...
Agonist of STING.
Diterpene found in Salvia.
Semi-synthetic avermectin; GABA potentiator.
Long chain acylcarnitine involved in fatty acid...
mTOR inhibitor.
CDK1/2 inhibitor.
Nucleoside (guanosine) analog; RT, guanylyl cyc...
JAK3 and EGFR inhibitor.
Cysteine-ITC conjugate, antioxidant.
Endogenous neuropeptide hormone, lowers extrace...
Triterpenoid found in Vigna angularis and Trigo...
Non-selective CB receptor agonist.
Diarylether; bacterial ENR binder, fatty acid s...
Prodrug
Phenothiazine derivative; D1/2 and 5-HT1A/2A an...
β-lactam; penicillin binding protein inhibitor...
Recombinant HCV antigen fragment.
Everolimus impurity